Vaccine testing for emerging infections: The case for individual randomisation

Journal of Medical Ethics

Volumn 43, Issue 9, 2017, Pages 625-631

  Eyal, Nir ^a   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE; VACCINE;

BENEFICENCE; COMMUNICABLE DISEASE; DEVELOPING COUNTRY; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; ETHICS; HUMAN; MEDICAL RESEARCH; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); ZIKA FEVER;

BENEFICENCE; BIOMEDICAL RESEARCH; COMMUNICABLE DISEASES, EMERGING; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; EBOLA VACCINES; HEMORRHAGIC FEVER, EBOLA; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; VACCINES; ZIKA VIRUS INFECTION;

EID: 85027570058     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2015-103220     Document Type: Article

References (47)

1. Cohen J, Kupferschmidt K. Tough choices ahead in Ebola vaccine trials. Sci Mag 2014 [ published Online First: October 7]
2. Cohen J. Issues continue to dog the testing of Ebola drugs and vaccines. Sci Mag 2014 [ published Online First: October 16]. http://news.sciencemag.org/health/ 2014/10/issues-continue-dog-testing-ebola-drugs-and-vaccines
3. Adebamowo C, Bah-Sow O, Binka F, et al. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014;384:1423-4
4. Kass N, Goodman S. Trials tempered by compassion and humility. New York Times December 1 2014
5. Caplan AL, Plunkett C, Levin B. Selecting the right tool for the job. Am J Bioeth 2015;15:4-10
6. O'Connor D. For immediate help, the ethics of research have to change. Guardian 11. October 2014
7. Presidential commission for the study of bioethical issues. Ethics and Ebola: Public health planning and response. Washington DC, 2015
8. Macklin R. Research Ethics and Ebola. Huffington Post, 2014
9. Boseley S. Ebola vaccine trials with placebo group would be unethical, scientists say. Guardian, October 10 2014
10. Draguez B. Ebola: On Experimental Treatments and Vaccines 2014 [updated October 17. http://www.doctorswithoutborders.org/article/ ebola-experimental-treatments-and-vaccines (accessed 11 Jun 2016)
11. Folayan MO, Yakubu A, Haire B, et al. Ebola vaccine development plan: ethics, concerns and proposed measures. BMC Med Ethics 2016;17:10
12. WHO Ebola Response Team. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med 2014;371:1481-95
13. Meltzer MI, Atkins CY, Santibanez S, et al. Estimating the future number of cases in the Ebola Epidemic-Liberia and Sierra Leone, 2014-2015. Atlanta: Centers for Disease Control and Prevention (CDC), 2014:1-14
14. Takahashi S, Metcalf CJ, Ferrari MJ, et al. Reduced vaccination and the risk of measles and other childhood infections post-Ebola. Science 2015;347:1240-2
15. Cox E, Borio L, Temple R. Evaluating Ebola therapies-the case for RCTs. N Engl J Med 2014;371:2350-1
16. Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med 2016;13:e1001967
17. Lipsitch M, Eyal N, Halloran E, et al. Vaccine testing: Ebola and beyond. Sci Mag 2015;348:46-8
18. Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015;386:857-66
19. Ebola ca Suffit Ring Vaccination Trial Consortium. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ 2015;351: h3740
20. WHO. Ethical considerations for use of unregistered interventions for Ebola viral disease (EVD)-WHO statement. Geneva: WHO, 2014 [updated August 12]. http:// www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/ (accessed 12 Aug 2014)
21. Halloran ME, Longini J, Ira M, et al. Design and analysis of vaccine studies. New York: Springer, 2010
22. Rid A. The goals of research during an epidemic. Am J Bioeth 2015;15:47-50
23. Toure A. People infected with Ebola would fear a placebo. New York Times 3 December 2014
24. Coleman CH. The Ethics of Using Placebo Controls in Ebola Clinical Trials. Health Reform Watch: Seton Hall, 2014
25. Qin E, Bi J, Zhao M, et al. Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis 2015;61:491-5
26. Pitzer VE, Leung GM, Lipsitch M. Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China. Am J Epidemiol 2007;166:355-63
27. Rid A, Miller FG. Ethical rationale for the Ebola "ring vaccination" trial design. Am J Public Health 2016;106:432-5
28. Doussau A, Grady C. Deciphering assumptions about stepped wedge designs: the case of Ebola vaccine research. J Med Ethics 2016; 42:797-804
29. Cohen IG, Daniels N, Eyal N, eds. Identified vs. statistical persons. New York: Oxford UP, 2015
30. Miller FG. The ethical challenges of human research: selected essays. 1st edn. New York: Oxford UP, 2012
31. Lilford RJ, Jackson J. Equipoise and the ethics of randomization. J R Soc Med 1995;88:552-9
32. Fried C. Medical experimentation: personal integrity and social policy. New York: North-Holland Publishing Company, 1974
33. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, 2014
34. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5
35. Ledgerwood JE, DeZure AD, Stanley DA, et al. Chimpanzee adenovirus vector Ebola vaccine-preliminary report. N Engl J Med 2017;376:928-38
36. Ewer K, Rampling T, Venkatraman N, et al. A Monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA. N Engl J Med 2016;374:1635-46
37. Ruble K. The End of Ebola: Inside the Race to Finish Vaccine Trials in Liberia 2015 [updated April 19]. https://news.vice.com/article/the-end-of-ebola-inside-the-race-tofinish-vaccine-trials-in-liberia (accessed 20 Apr 2015)
38. Branswell H. Halted study of Canadian Ebola vaccine resumes with lower dose: CTV News; 2015 [updated January 6]. http://www.ctvnews.ca/health/halted-study-ofcanadian-ebola-vaccine-resumes-with-lower-dose-1.2174655 (accessed 29 Jan 2015)
39. Lemmens T, Miller PB. Avoiding a Jekyll-And-Hyde approach to the ethics of clinical research and practice. Am J Bioeth 2002;2:14-17
40. Duerr A, Huang Y, Buchbinder Y, et al. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step study). J Infect Dis 2012;206:258-66
41. Wasunna M. In Africa, broader ethical considerations are common. New York Times 1 December 2014
42. Selgelid M. Ethics Perspective on Proposed Emergency Use of Vaccine in Affected Countries in Parallel with Phase 2 Clinical Trials. Geneva, Switzerland: WHO consultation on Ebola vaccines. 2014
43. GSK staff. Our contribution to the fight against Ebola 2015. http://www.gsk.com/ en-gb/our-stories/health-for-all/our-contribution-to-the-fight-against-ebola/ (accessed 29 Jan 2015)
44. Moses L. Don't ignore established research ethics when treating Ebola. New York Times, 1 December 2014
45. Fleck F, Lesher A. The race against time. Bull World Health Organ 2015;93:7-8
46. WHO Ethics Working Group. Ethical issues related to study design for trials on therapeutics for Ebola virus disease, 20-21 October meeting, 2014
47. Bellan SE, Pulliam JR, Pearson CA, et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis 2015;15:703-10